The Company announced that the Company’s board of directors has authorized a program for the purpose of repurchasing up to $40 million worth of the outstanding shares of the Company’s 7.50% Series 2023 Term Preferred Stock, 6.75% Series 2024 Term Preferred Stock and 6.25% Series 2027 Term Preferred Stock (collectively, the “Preferred Stock”). Under this repurchase program, the Company may, but is not obligated to, repurchase its outstanding Preferred Stock in the open market from time to time through September 30, 2020. The timing and number of preferred shares to be repurchased will depend on a number of factors, including market conditions and alternative investment opportunities. In addition, any repurchases will also be conducted in accordance with the Investment Company Act of 1940, as amended. There are no assurances that the Company will engage in any repurchases. As of 2020-05-20, the Fund’s leverage was 30.4% and Collateralized Loan Obligation Group leverage was 26.7%.